The Global Knowledge Center (GKC) is an education hub designed to meet the educational needs of all healthcare professionals, including the navigator and oncology team, community health, and primary care providers who have touchpoints and care for the lung cancer community. Powered by the latest learning technology, its relevant and transformative education can help improve the quality of life and survival for at-risk, vulnerable, underserved, and marginalized populations.
Explore Global Knowledge Center Courses
-
.jpg)
Understanding NSCLC Histology and Oncogenesis of HER2 (ERBB2) Mutation in NSCLC
CourseThis course reviews NSCLC histologic subtypes and HER2 alterations, including mutation, amplification, and overexpression, and explains how HER2-driven signaling pathways (MAPK, PI3K/AKT, PKC, STAT) promote tumor growth and progression.
Enroll for freeFree
-
.png)
Biomarker Testing in Non-Small Cell Lung Cancer Diagnosis
CourseExplore the role of comprehensive NGS testing across the NSCLC care continuum, compare biomarker testing strategies, and examine how early identification of HER2 (ERBB2) mutations can inform precision treatment decisions.
Free
-
Precision Oncology in HER2 (ERBB2) Mutation and Guideline-Directed Targeted Therapies
CourseExplore the biology, diagnosis, and management of HER2 (ERBB2)-mutant NSCLC, including molecular characteristics, prognostic implications, targeted therapies, clinical trial evidence, guideline-directed care, and treatment-related toxicities.
Free
-
.png)
Managing Toxicities of Targeted Therapies
CourseLearn to recognize and manage toxicities associated with platinum-based, immunotherapy, and HER2-targeted therapies in NSCLC. Explore proactive strategies to prevent, monitor, and mitigate adverse events to optimize patient outcomes.
Free
-
.png)
Closing Gaps in Personalized NSCLC Care Through Implementation of High-Quality Precision Programs
CourseExplore patient-centered strategies to optimize comprehensive NGS testing, streamline biomarker-driven care, leverage collaborative care models and telehealth, and use quality metrics to improve outcomes for patients with HER2 (ERBB2)-mutant NSCLC.
Free
-
Molecular Tumor Boards (MTBs) and Precision Oncology Programs
CourseExplore the role of molecular tumor boards in NSCLC care, including their impact on biomarker testing, treatment initiation for HER2-mutant disease, and integration into clinical workflows to support personalized treatment decisions.
Free
-
Financial Toxicity and Policy Implications for Access to Biomarker Testing and Targeted Therapies
CourseExplore how healthcare policy, insurance coverage, and financial toxicity influence access to comprehensive biomarker testing and targeted therapies and examine solutions to advance equitable access to precision oncology.
Free